Using LC-MS/MS, we profiled changes in COX, LOX, and CYP450-epoxygenase metabolic products derived from N−3 and N−6 PUFAs in DCM human heart tissue compared to NFC (Table 2). The gene discussed is LOX; the disease is familial dilated cardiomyopathy.